Company Presentation • 28 Apr 2026 22:00
Company Presentation • 06 Mar 2026 00:42
Company Presentation • 04 Nov 2025 21:00
Company Presentation • 31 Oct 2025 20:00
Company Presentation • 07 Aug 2025 20:00
𝛼SK or SearchENTITY
HUTCHMED (HCM LN)
HUTCHMED (HCM LN)
26
Analysis
Health Care • Hong Kong
HUTCHMED is an innovative, commercial-stage biopharmaceutical company committed to the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has established a fully integrated R&D platform and a profitable commercial platform in China. It is headquartered in Hong Kong and was founded in 2000.
morex